Morgan Stanley Regenxbio Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Regenxbio Inc. stock. As of the latest transaction made, Morgan Stanley holds 1,349,876 shares of RGNX stock, worth $10.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,349,876

Previous 1,179,852 14.41%

Holding current value

$10.3 Million

Previous $13.8 Million 2.58%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$10.49 - $14.39 $1.78 Million - $2.45 Million	170,024 Added 14.41%	1,349,876 $14.2 Million
Q2 2024 Oct 17, 2024	SELL	$11.51 - $21.53 $1.84 Million - $3.44 Million	-159,986 Reduced 11.94%	1,179,852 $13.8 Million
Q2 2024 Aug 14, 2024	SELL	$11.51 - $21.53 $1.84 Million - $3.44 Million	-159,986 Reduced 11.94%	1,179,852 $13.8 Million
Q1 2024 Oct 17, 2024	BUY	$12.17 - $24.61 $1.95 Million - $3.94 Million	159,986 Added 13.56%	1,339,838 $28.2 Million
Q1 2024 Aug 16, 2024	SELL	$12.17 - $24.61 $5.85 Million - $11.8 Million	-480,544 Reduced 26.4%	1,339,838 $28.2 Million
Q1 2024 May 15, 2024	SELL	$12.17 - $24.61 $5.85 Million - $11.8 Million	-480,544 Reduced 26.4%	1,339,838 $28.2 Million
Q4 2023 Aug 16, 2024	BUY	$12.89 - $20.82 $8.26 Million - $13.3 Million	640,530 Added 54.29%	1,820,382 $32.7 Million
Q4 2023 Feb 13, 2024	BUY	$12.89 - $20.82 $18.5 Million - $29.9 Million	1,438,467 Added 376.65%	1,820,382 $32.7 Million
Q3 2023 Nov 15, 2023	BUY	$16.46 - $19.99 $59,074 - $71,744	3,589 Added 0.95%	381,915 $6.29 Million
Q2 2023 Aug 14, 2023	BUY	$17.23 - $21.71 $857,382 - $1.08 Million	49,761 Added 15.14%	378,326 $7.56 Million
Q1 2023 May 15, 2023	BUY	$18.08 - $24.55 $336,215 - $456,531	18,596 Added 6.0%	328,565 $6.21 Million
Q4 2022 Feb 14, 2023	SELL	$20.4 - $24.73 $777,321 - $942,311	-38,104 Reduced 10.95%	309,969 $7.03 Million
Q3 2022 Nov 14, 2022	SELL	$22.29 - $35.04 $3.54 Million - $5.56 Million	-158,675 Reduced 31.31%	348,073 $9.2 Million
Q2 2022 Oct 27, 2022	BUY	$19.35 - $35.04 $1.99 Million - $3.61 Million	102,901 Added 25.48%	506,748 $12.5 Million
Q2 2022 Aug 15, 2022	BUY	$19.35 - $35.04 $1.99 Million - $3.61 Million	102,901 Added 25.48%	506,748 $12.5 Million
Q1 2022 Oct 27, 2022	SELL	$24.62 - $34.31 $2.53 Million - $3.53 Million	-102,901 Reduced 20.31%	403,847 $13.4 Million
Q1 2022 May 13, 2022	SELL	$24.62 - $34.31 $748,940 - $1.04 Million	-30,420 Reduced 7.0%	403,847 $13.4 Million
Q4 2021 Feb 14, 2022	BUY	$30.19 - $40.28 $2.81 Million - $3.75 Million	93,111 Added 27.29%	434,267 $14.2 Million
Q3 2021 Nov 15, 2021	BUY	$29.09 - $45.68 $9.92 Million - $15.6 Million	341,156 New	341,156 $14.3 Million

Others Institutions Holding RGNX

# of Institutions

196

Shares Held

43M

Call Options Held

104K

Put Options Held

478K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $329M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account